Shares of Medtronic PLC MDT shed 1.52% to $88.49 Tuesday, on what proved to be an all-around mixed trading session for the ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Here are two blue-chip value stocks I'm steadily accumulating right now. What makes this discount particularly compelling is ...

Medtronic has reported late-breaking data from the randomised Evolut Low Risk Trial’s five-year outcomes of the Evolut ...

Budgeted spending for NIH BRAIN Initiative has plunged by more than half, from $680 million in 2023 to $320 million this year ...

Shares of Medtronic PLC MDT rallied 2.54% to $89.86 Monday, on what proved to be an all-around great trading session for the ...

The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Mastercard Inc. (MA), Medtronic plc ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...

An advanced hybrid closed-loop insulin delivery system is safe to use for pregnant women with type 1 diabetes and may provide ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Medtronic (MDT – Research Report), with a price target of ...

Stifel Nicolaus analyst Rick Wise maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $87.00. The ...